179 related articles for article (PubMed ID: 1962275)
21. [Therapeutic roles of nuclear medicine].
Bisson G; Chartrand R
Union Med Can; 1990; 119(4):175-7. PubMed ID: 2201115
[No Abstract] [Full Text] [Related]
22. Criteria for the selection of radionuclides for targeting nuclear antigens for cancer radioimmunotherapy.
Srivastava SC
Cancer Biother Radiopharm; 1996 Feb; 11(1):43-50. PubMed ID: 10851519
[TBL] [Abstract][Full Text] [Related]
23. Practical assessment of radiation doses using labelled antibodies for therapy.
Myers MJ; Epenetos AA; Hooker G
Int J Rad Appl Instrum B; 1986; 13(4):437-46. PubMed ID: 3793499
[TBL] [Abstract][Full Text] [Related]
24. Radionuclides and carrier molecules for therapy.
Zweit J
Phys Med Biol; 1996 Oct; 41(10):1905-14. PubMed ID: 8912370
[TBL] [Abstract][Full Text] [Related]
25. Future role of radiolabeled monoclonal antibodies in oncological diagnosis and therapy.
Goldenberg DM
Semin Nucl Med; 1989 Oct; 19(4):332-9. PubMed ID: 2678484
[TBL] [Abstract][Full Text] [Related]
26. [Remission incidence and adverse effects in low-dosage radioactive phosphorus therapy of polycythemia vera].
Hauswaldt C; Horejschi J; Emrich D; Heckner F; Douwes FW; Ziesemer G
Verh Dtsch Ges Inn Med; 1975; 81():1128-30. PubMed ID: 1229414
[No Abstract] [Full Text] [Related]
27. Radio nuclides in radiotherapy.
Gajaraj A
J Assoc Physicians India; 1978 Feb; 26(2):71-8. PubMed ID: 730678
[No Abstract] [Full Text] [Related]
28. Dosimetric aspects of radiolabeled antibodies for tumor therapy.
Humm JL
J Nucl Med; 1986 Sep; 27(9):1490-7. PubMed ID: 3528417
[TBL] [Abstract][Full Text] [Related]
29. [Radiophosphorus therapy of polycythemia vera].
Hör G; Pabst HW
Ther Umsch; 1973 Nov; 30(11):789-96. PubMed ID: 4591693
[No Abstract] [Full Text] [Related]
30. [Radioactive phosphorus (32P); an old, but not bad treatment in polycythemia vera].
Michiels JJ; van Genderen PJ
Ned Tijdschr Geneeskd; 1997 Jan; 141(3):168-9. PubMed ID: 9053768
[No Abstract] [Full Text] [Related]
31. Lymphoma, melanoma, colon cancer: diagnosis and treatment with radiolabeled monoclonal antibodies. The 1986 Eugene P. Pendergrass New Horizons Lecture.
Larson SM
Radiology; 1987 Nov; 165(2):297-304. PubMed ID: 3498971
[TBL] [Abstract][Full Text] [Related]
32. [Use of radionuclides in therapy].
Vucina J; Han R
Med Pregl; 2001; 54(5-6):245-50. PubMed ID: 11759220
[TBL] [Abstract][Full Text] [Related]
33. [Treatment with radioisotopes].
McDougall IR
Internist (Berl); 1978 Jul; 19(7):431-6. PubMed ID: 357330
[No Abstract] [Full Text] [Related]
34. Anti-cancer radiopharmaceuticals.
Hoefnagel CA
Anticancer Drugs; 1991 Apr; 2(2):107-32. PubMed ID: 1958857
[TBL] [Abstract][Full Text] [Related]
35. A new calculational method to assess the therapeutic potential of Auger electron emission.
Humm JL; Charlton DE
Int J Radiat Oncol Biol Phys; 1989 Aug; 17(2):351-60. PubMed ID: 2753759
[TBL] [Abstract][Full Text] [Related]
36. 5-(125I)-iododeoxyuridine and the Auger effect: biological consequences and implications for therapy.
Bloomer WD; Adelstein SJ
Pathobiol Annu; 1978; 8():407-21. PubMed ID: 364377
[TBL] [Abstract][Full Text] [Related]
37. Time-dose-fractionation in radioimmunotherapy: implications for selecting radionuclides.
Rao DV; Howell RW
J Nucl Med; 1993 Oct; 34(10):1801-10. PubMed ID: 8410301
[TBL] [Abstract][Full Text] [Related]
38. Technology in nursing: Radiotherapy. 11. Unsealed radioactive isotopes in treatment.
Harmer C
Nurs Times; 1979 Dec 20-27; 75(51):suppl 41-4. PubMed ID: 260109
[No Abstract] [Full Text] [Related]
39. The role of radioisotopes in radiation oncology.
Park CH
Semin Oncol; 1997 Dec; 24(6):639-54. PubMed ID: 9422261
[TBL] [Abstract][Full Text] [Related]
40. Radiation absorbed dose estimates at the cellular level for some electron-emitting radionuclides for radioimmunotherapy.
Jungerman JA; Yu KH; Zanelli CI
Int J Appl Radiat Isot; 1984 Sep; 35(9):883-8. PubMed ID: 6480148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
